ArticleArchives of Razi Institute2023
Anticandidal Effects of Zinc Oxide Nanoparticles on Fluconazole-Resistant
Article in Archives of Razi Institute, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 citations in OpenAlex.
- Zinc oxide nanoparticles againstFrontiers in antibiotics · 2026Review
- Dual-Cross-Linked Alginate Hydrogels as a Strategy to Improve the Antifungal Properties of Posaconazole.Pharmaceutics · 2025Article
- Zinc Oxide Nanoparticles as Next-Generation Feed Additives: Bridging Antimicrobial Efficacy, Growth Promotion, and Sustainable Strategies in Animal Nutrition.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal disease in calves may pose a significant threat to the livestock industry. Due to the increased rate of resistance to antifungal drugs and the side effects of these drugs, it is essential to find suitable alternatives, such as nanoparticles, with favorable antifungal effects and few side effects. This study aimed to determine the frequency of yeast causing diarrhea in calves and evaluate zinc oxide nanoparticles' antifungal effects on fluconazole-resistant isolates. Fecal samples from 94 calves (age < three months old) with clinical signs of diarrhea were examined by standard microbiological and biochemical methods. The broth microdilution method evaluated the susceptibility of fungi to fluconazole and the antimicrobial activity of zinc oxide nanoparticles on drug-resistant isolates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.